If Amyloid Fails, We Are 15 Years Away from Having a Treatment Industry is in the business of developing products. For Alzheimer’s disease this has… Read more
Nsight Barbara Nelsen on the business of science.
Okay, @gdombal I will concede that Boston is the center of the universe for biopharma/biotech (for now), though I maintain Minnesota still retains its dominance in all… Read more
Minnesota is known as a leader in medical device and healthcare and its presence in biopharma is growing. Adding to the list of exciting companies… Read more
With the start of the new year and JP Morgan next week, it’s time to start planning your 2017 life science capital investment campaign. Here are… Read more
In Part 1 of this series, we highlight what investors want to see in a company’s business plan and hear in the pitch in order… Read more